You are here:Home-Chemical Inhibitors & Agonists-Metabolic Enzyme/Protease-Phosphodiesterase (PDE)-MCI-030
MCI-030

Chemical Structure : MCI-030

CAS No.: 2700025-84-7

MCI-030 (ADT 061)

Catalog No.: PC-49420Not For Human Use, Lab Use Only.

MCI-030 (ADT 061) is a potent, selective PDE10 inhibitor, inhibits recombinant PDE10 using cGMP as a substrate with IC50 of 0.3 uM.

Packing Price Stock Quantity
25 mg Get quote
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

    Biological Activity

    MCI-030 (ADT 061) is a potent, selective PDE10 inhibitor, inhibits recombinant PDE10 using cGMP as a substrate with IC50 of 0.3 uM.
    MCI-030 (ADT 061) is specific for PDE10 and shows no appreciably affecting the activity of all other PDE isozymes.
    MCI-030 (ADT 061) completely lacked COX-1 or COX-2 inhibitory activity at concentrations up to 50 μM.
    MCI-030 (ADT 061) potently inhibited the growth of colon cancer cell lines, HCT116, HT-29, and SW480, with IC50 values of 0.31, 0.33, and 0.37 μM, respectively, but did not appreciably affect the growth of normal colon mucosal (NCM460) cells up to 50 μM.
    ADT 061 activates cGMP/PKG signaling and suppresses oncogenic β-catenin TCF/LEF transcriptional activity in HT-29 colon cancer cells, blocks Wnt-induced nuclear translocation of β-catenin.
    MCI-030 (ADT 061) decreased ovarian cancer cell growth and induced cell cycle arrest and apoptosis in vitro.
    MCI-030 (ADT 061) inhibited colon adenomas in the Apc+/Min-FCCC mouse model, orally active.

    Physicochemical Properties

    M.Wt 472.541
    Formula C28H28N2O5
    Appearance Solid
    CAS No.
    Storage
    Solide Powder
    -20°C 12 Months; 4°C 6 Months
    In Solvent
    -80°C 6 Months; -20°C 6 Months
    Shipping
    Solubility

    10 mM in DMSO

    Chemical Name/SMILES

    (Z)-2-(5-methoxy-2-methyl-1-(3,4,5-trimethoxybenzylidene)-1H-inden-3-yl)-N-(pyridin-3-yl)acetamide

    References

    1. Kevin J Lee, et al. Cancer Prev Res (Phila). 2021 Nov;14(11):995-1008.

    2. Borneman RM, et al. J Ovarian Res. 2022 Nov 2;15(1):120.

    Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

    Contact Us sales@probechem.com

    Bulk Inquiry

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • *Additional Information:

    Get Quote

    * Indicates a Required FieldYour information is safe with us.

    • *Product name:
    • *Applicant name:
    • *Email address:
    • *Organization name:
    • *Requested quantity:
    • *Country:
    • Additional Information: